Hepatitis Central

The latest research & treatment news about Hepatitis C infection, diagnosis, symptoms and treatments.

Hepatitis C Drug ITMN-191 Appears Safe

April 4, 2008

Printer-friendly version

Bookmark and Share

In addition to demonstrating a Hepatitis C anti-viral effect, an early trial investigating ITMN-191 met safety goals. With this good news, a Phase II study will evaluate this drug in combination with pegylated interferon and ribavirin.

InterMune Hepatitis C Drug Passes Study
© 2008 The Associated Press

April 1, 2008, 9:48AM

www.chron.com

BRISBANE, Calif. — Biotechnology company InterMune Inc. said Tuesday its hepatitis C drug candidate met safety goals in an early stage clinical trial and showed signs of effectiveness.

The drug candidate ITMN-191, being developed with Swiss drug company Roche, reduced hepatitis C RNA in the small-scale study, showing an antiviral effect. Early stage clinical trials typically measure a drug's safety profile and whether it reaches its treatment target. The patient population is often too small to determine whether the drug candidate is actually effective.

The two companies plan a 14-day study on the drug in combination with two approved drugs, Pegasys and Copegus, also called ribavirin. An application was submitted to European regulatory authorities last month for the triple-combination study. Also, Roche has completed the tablet formulation of ITMN-191 and will use it in a midstage, or Phase II, clinical trial.

Shares of InterMune rose $2.84, or 19.1 percent, to $17.42. The stock has traded between $11.72 and $30.99 over the last 52 weeks.

Posted by Editors at April 4, 2008 3:27 PM

Site Topics

  • HCV Symptoms

    You'll find links to a comprehensive symptoms list, as well as various studies and discussions about Hepatitis C symptoms.

  • Lab Tests

    What they are and what they mean. Helps you interpret & understand all the various hepatitis lab tests likely to be encountered.

  • Hepatitis C Genotypes

    Learn about Hepatitis C Genotypes and their variants.

  • Viral Load

    Includes a convenient Viral Load chart, as well as a link to a detailed discussion on how to analyze and interpret viral load numbers.

  • What is...?

    Learn more about various Hepatitis C related topics, including HCV, Ascites, Biopsies, and much more.

  • HCV Medicines

    Numerous links to studies, info sheets, FAQs, and analysis of Ribavirin/Rebetron medicines.

  • Hepatitis C Doctors

    A state-by-state and worldwide reference listing physicians who treat HCV, including an email link to submit your physician for inclusion.

  • Biopsy Info

    A comprehensive resource of information relating to the liver biopsy.

  • Cirrhosis

    Many discussions and analyses of cirrhosis, including causes, complications, pathology, symptoms, and much more.

  • Liver Cancer

    Liver Cancer/Hepatocellular Carcinoma studies, info sheets, FAQs, and analysis.

  • Liver Disease Medicines

    An exhaustive list of links to studies, info sheets, FAQs, and analysis of the various drugs used to treat liver disease.

  • Hep-Central Email List

    Sign up to learn about advances and breakthroughs in Hepatitis C research, including information about medical and complementary treatments.

  • HCV Links

    Convenient links to other sites external to Hepatitis-Central.

  • Mother/Child Transmission

    Discussions of the special problems and precautions necessary involving mother to child transmission of Hepatitis C.

  • HCV Natural Remedies

    A number of herbal products useful in the management of liver disease.

  • HCV Books

    Recommended reading for those interested in hepatitis information.

  • Hepatitis C Forum

    A Bulletin Board for discussions on hepatitis, treatments, etc.

  • Hepatitis C Activism

    An easy way to get involved in urging our government to do more for Hepatitis C awareness and treatment research.

Advertisement

Search R&T News

Advertisement